Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Return on Capital Employed [ROCE] (2020 - 2024)

Updated

Summit Therapeutics (SMMT) reported Return on Capital Employed [ROCE] of -52.87% for Q4 2024, up 267.48 percentage points from -320.35% a year earlier and up 1.24 percentage points from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Return on Capital Employed [ROCE] (2020 - 2024) Analysis & Trends

For FY2024, Summit Therapeutics posted Return on Capital Employed [ROCE] of -81.43%, up 66.13 percentage points from FY2023.

  • Return on Capital Employed [ROCE] has a four-year change of -14.51 percentage points (FY2020 to FY2024).
  • By year, Return on Capital Employed [ROCE] came in at -147.56% in FY2023 (-126.96 pp), -20.60% in FY2022 (+84.11 pp), -104.71% in FY2021 (-37.78 pp) and -66.92% in FY2020.
  • The Q4 2024 figure ranks as the highest quarterly Return on Capital Employed [ROCE] since Q4 2022.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last four quarters, with an average year-over-year change of -3.84 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2024 (a gain of 465.89 percentage points); the low point was Q3 2023 (a drop of 448.48 percentage points).
  • Per Business Quant data, the three quarters before Q4 2024 came in at -54.11% (Q3 2024), -133.20% (Q2 2024) and -69.03% (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 17.83%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 17.92%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.28%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 19.32%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 9.54%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 16.66%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -5.97%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.76%
10 Summit Therapeutics 12.28 Bn 10.04 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -52.87%
Sep 30, 2024 -54.11%
Jun 30, 2024 -133.20%
Mar 31, 2024 -69.03%
Dec 31, 2023 -320.35%
Sep 30, 2023 -519.99%
Jun 30, 2023 -252.00%
Mar 31, 2023 -132.80%
Dec 31, 2022 -19.43%
Sep 30, 2022 -71.51%
Jun 30, 2022 -88.41%
Mar 31, 2022 -99.16%
Dec 31, 2021 -90.34%
Sep 30, 2021 -62.72%
Jun 30, 2021 -57.02%
Mar 31, 2021 -125.07%
Dec 31, 2020 -108.08%
API Access

Summit Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SMMT&period=max&api_key=YOUR_API_KEY